Company intelligence / Profile preview

Transplant Biomedicals

Barcelona, Catalunya/Catalonia, Spainza.linkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Transplant Biomedicals developed VIVIAN®, a next-generation disposable medical device using hypothermic ultrasound to improve kidney transplant outcomes. Interim first-in-human results showed superior performance compared to static cold storage, supporting the potential to increase usable donor organs and reduce waiting lists. The company aimed to expand into liver and heart applications but was still pre-commercial at last report.

Therapeutic areas: OtherImmunology
Modalities: DeviceMedical deviceHypothermic Ultrasound Preservation Technology (HUPT)
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Transplant Biomedicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transplant Biomedicals.

Explore the full profile